Latest From Biotech Now

Show Me the Money: Reimbursement in an ACA World

BIO CEO 2013

A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a variety of perspectives and agreed that the landscape is shifting dramatically. The reimbursement roundtable featured payors, providers, and other stakeholders discussing Affordable Care Act (ACA) implementation and the wider reimbursement landscape. With many key provisions of the ACA slated to take effect in 2013 and beyond, the industry is facing sweeping changes to the managed care and reimbursement road map. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

More Farmers Around the World Plant Biotech Crops

Farmer

ISAAA (International Service for the Acquisition of Agri-Biotech Applications) released their annual report last week on the Global Status of Commercialized Biotech/GM Crops: 2012, showing a record 17.3 million farmers in 28 countries are growing biotech crops on 420 million acres. That marks a pretty stunning 100-fold increase since biotech crops were first commercialized in 1996. Even more impressive is the role developing countries are playing in the growth of biotech crops. Business-Standard.com reported on Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Orphan Drugs: Making Rare Diseases Rarer

Panel

A panel at the BIO CEO & Investor Conference provided an analysis of the thriving orphan drug market opportunity featuring industry, clinical and regulatory experts specializing in rare diseases. The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering innovation for rare diseases. With a record 460 medicines in late-stage clinical trials, biopharmaceutical companies have embraced rare disease medicine and are rapidly developing the pipeline with hopes of achieving the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Putting a Ring on It: Advice on Successful Drug Development Collaborations

Ring

Drug development partnerships can look lucrative to small biotechs eager to monetize their discoveries, but, like any relationship, these tie-ups take work and both parties run the risk of ending up in tears. At BIO’s recent CEO & Investor Conference, a panel of industry veterans gathered to discuss best practices in drug development partnering. Moderated by Jeff Stewart, Senior Engagement Manager with Campbell Alliance, the panel “Putting a Ring on it: When Drug Development Partnerships Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

When it Comes to Biofuels Driving the Economy, The Sky is the Limit

Refinery

Last week, Agriculture Secretary Tom Vilsack wrote a column talking about the unlimited opportunities for biofuels to grow the rural economy. He highlighted what the United States Department of Agriculture (USDA) has already done to support biofuels including loan guarantees and research centers, and talked about the contributions biofuels have already made to strengthen our nation’s economic and energy security. The United States is rapidly building a biobased economy, where biotechnology is used to convert Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,